News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
144,512 Results
Type
Article (10077)
Company Profile (2)
Press Release (134433)
Multimedia
Podcasts (13)
Webinars (4)
Section
Business (32410)
Career Advice (257)
Deals (5107)
Drug Delivery (34)
Drug Development (25895)
Employer Resources (43)
FDA (4536)
Job Trends (3464)
News (69210)
Policy (7673)
Tag
2024 Biotech Bay Standard (1)
2026 BioCapital Standard (1)
Academia (811)
Adcomms (4)
Allergies (32)
Alliances (6772)
ALS (18)
Alzheimer's disease (313)
Antibody-drug conjugate (ADC) (25)
Approvals (4572)
Artificial intelligence (33)
Autoimmune disease (6)
Automation (3)
Bankruptcy (35)
Best Places to Work (3129)
BIOSECURE Act (9)
Biosimilars (27)
Biotechnology (1)
Bladder cancer (32)
Brain cancer (6)
Breast cancer (72)
Cancer (667)
Cardiovascular disease (65)
Career advice (237)
Career pathing (5)
CAR-T (45)
Cell therapy (105)
Cervical cancer (7)
Clinical research (21229)
Collaboration (106)
Compensation (8)
Complete response letters (6)
COVID-19 (662)
CRISPR (14)
C-suite (26)
Cystic fibrosis (28)
Data (768)
Decentralized trials (2)
Depression (7)
Diabetes (78)
Diagnostics (1604)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (19)
Drug pricing (45)
Drug shortages (7)
Duchenne muscular dystrophy (23)
Earnings (13494)
Editorial (13)
Employer branding (4)
Employer resources (38)
Events (26654)
Executive appointments (98)
FDA (4827)
Featured Employer (2)
Frontotemporal dementia (2)
Funding (101)
Gene editing (34)
Generative AI (2)
Gene therapy (71)
GLP-1 (172)
Government (1246)
Grass and pollen (2)
Guidances (7)
Healthcare (5299)
Huntington's disease (1)
IgA nephropathy (12)
Immunology and inflammation (20)
Indications (13)
Infectious disease (693)
Inflammatory bowel disease (33)
Inflation Reduction Act (4)
Influenza (13)
Intellectual property (17)
Interviews (23)
IPO (2757)
IRA (14)
Job creations (461)
Job search strategy (220)
Kidney cancer (5)
Labor market (4)
Layoffs (70)
Leadership (4)
Legal (1106)
Liver cancer (21)
Lung cancer (99)
Lymphoma (61)
Machine learning (1)
Management (17)
Manufacturing (48)
MASH (23)
Medical device (2997)
Medtech (2999)
Mergers & acquisitions (2449)
Metabolic disorders (174)
Multiple sclerosis (8)
NASH (2)
Neurodegenerative disease (17)
Neuropsychiatric disorders (1)
Neuroscience (411)
NextGen: Class of 2025 (1620)
Non-profit (1869)
Northern California (551)
Obesity (83)
Opinion (46)
Ovarian cancer (16)
Pain (24)
Pancreatic cancer (38)
Parkinson's disease (38)
Partnered (4)
Patents (30)
Patient recruitment (29)
Peanut (17)
People (10343)
Pharmaceutical (2)
Pharmacy benefit managers (11)
Phase I (5746)
Phase II (8696)
Phase III (7908)
Pipeline (299)
Policy (53)
Postmarket research (1250)
Preclinical (2924)
Press Release (3)
Prostate cancer (37)
Psychedelics (3)
Radiopharmaceuticals (50)
Rare diseases (103)
Real estate (765)
Recruiting (10)
Regulatory (5921)
Reports (7)
Research institute (573)
Resumes & cover letters (18)
RSV (12)
Schizophrenia (8)
Series A (11)
Series B (9)
Sickle cell disease (26)
Southern California (466)
Special edition (4)
Spinal muscular atrophy (27)
Sponsored (5)
Startups (403)
Stomach cancer (1)
Supply chain (11)
Tariffs (5)
The Weekly (13)
United States (4828)
Vaccines (153)
Venture capitalists (6)
Weight loss (43)
Women's health (10)
Worklife (3)
Date
Today (44)
Last 7 days (136)
Last 30 days (618)
Last 365 days (7492)
2025 (2010)
2024 (8312)
2023 (9405)
2022 (11111)
2021 (11971)
2020 (11675)
2019 (11696)
2018 (8932)
2017 (6794)
2016 (6660)
2015 (7741)
2014 (5822)
2013 (4539)
2012 (4840)
2011 (5280)
2010 (4937)
Location
Africa (145)
Alabama (27)
Alaska (3)
Arizona (33)
Arkansas (4)
Asia (7562)
Australia (1255)
California (1204)
Canada (357)
China (136)
Colorado (48)
Connecticut (67)
Delaware (38)
Europe (17708)
Florida (207)
Georgia (45)
Idaho (9)
Illinois (144)
India (7)
Indiana (82)
Iowa (1)
Japan (45)
Kansas (21)
Kentucky (7)
Louisiana (3)
Maine (4)
Maryland (261)
Massachusetts (841)
Michigan (49)
Minnesota (70)
Mississippi (1)
Missouri (27)
Montana (11)
Nebraska (3)
Nevada (18)
New Hampshire (9)
New Jersey (501)
New Mexico (8)
New York (334)
North Carolina (229)
North Dakota (3)
Northern California (551)
Ohio (40)
Oklahoma (2)
Oregon (4)
Pennsylvania (230)
Rhode Island (4)
South America (287)
South Carolina (12)
Southern California (466)
Tennessee (24)
Texas (141)
Utah (24)
Virginia (48)
Washington D.C. (26)
Washington State (128)
Wisconsin (12)
144,512 Results for "american geophysical union agu".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
April 16, 2025
·
18 min read
Press Releases
Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars
February 18, 2025
·
8 min read
Press Releases
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
January 31, 2025
·
9 min read
Press Releases
Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor
March 3, 2025
·
19 min read
Alzheimer’s disease
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi
The European Union’s CHMP said that the benefits of the drug, already approved in the U.S., do not outweigh the risk of potentially fatal brain swelling and bleeding.
March 28, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
February 27, 2025
·
7 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
January 24, 2025
·
3 min read
Press Releases
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
February 14, 2025
·
13 min read
Press Releases
4M Therapeutics to Present at the Upcoming American Psychological Association and American Society of Clinical Psychopharmacology Annual Meetings
April 21, 2025
·
1 min read
1 of 14,452
Next
